CAM
VYNE icon

Cormorant Asset Management’s VYNE Therapeutics VYNE Stock Holding History

Cormorant Asset Management’s Portfolio VYNE Stock Details VYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,370,938
Closed -$2.26M – 43
2025
Q2 		$2.26M Buy
+1,370,938
New +$1.78M 0.17% 41
2025
Q1 		– Sell
-1,394,336
Closed -$4.67M – 50
2024
Q4 		$4.67M Hold
1,394,336
– – 0.26% 38
2024
Q3 		$2.62M Hold
1,394,336
– – 0.14% 42
2024
Q2 		$2.75M Hold
1,394,336
– – 0.16% 46
2024
Q1 		$4.28M Hold
1,394,336
– – 0.19% 56
2023
Q4 		$3.25M Buy
+1,394,336
New +$4.35M 0.16% 46
2018
Q2 		– Sell
-4,677
Closed -$12.7M – 61
2018
Q1 		$12.7M Buy
+4,677
New +$11.4M 1.1% 25

Other funds holding VYNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SC
Shay Capital New York $704M AUM 37.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return